WO2014194675A1 - Windowing method for covered stent in vascular cavity and windowing device for covered stent in vascular cavity - Google Patents
Windowing method for covered stent in vascular cavity and windowing device for covered stent in vascular cavity Download PDFInfo
- Publication number
- WO2014194675A1 WO2014194675A1 PCT/CN2014/070695 CN2014070695W WO2014194675A1 WO 2014194675 A1 WO2014194675 A1 WO 2014194675A1 CN 2014070695 W CN2014070695 W CN 2014070695W WO 2014194675 A1 WO2014194675 A1 WO 2014194675A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stent graft
- vascular
- stent
- laser
- elastic metal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
- A61B2090/378—Surgical systems with images on a monitor during operation using ultrasound
- A61B2090/3782—Surgical systems with images on a monitor during operation using ultrasound transmitter or receiver in catheter or minimal invasive instrument
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/06—Devices, other than using radiation, for detecting or locating foreign bodies ; Determining position of diagnostic devices within or on the body of the patient
- A61B5/065—Determining position of the probe employing exclusively positioning means located on or in the probe, e.g. using position sensors arranged on the probe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/12—Arrangements for detecting or locating foreign bodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Clinical applications
- A61B8/0833—Clinical applications involving detecting or locating foreign bodies or organic structures
- A61B8/0841—Clinical applications involving detecting or locating foreign bodies or organic structures for locating instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Clinical applications
- A61B8/0891—Clinical applications for diagnosis of blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/12—Diagnosis using ultrasonic, sonic or infrasonic waves in body cavities or body tracts, e.g. by using catheters
Definitions
- the invention relates to the technical field of intravascular stent grafts, in particular to a method for opening a window in a vascular lumen and a fenestration device for a stent in a vascular lumen.
- Aortic aneurysm is the most common aneurysm and is a major vascular disease that seriously threatens human life.
- the incidence of aortic aneurysm has increased year by year, which has become one of the common causes of sudden death in middle-aged and elderly people.
- the cause is mainly degenerative lesions in the middle aorta, which in turn leads to a weakening of the aortic wall and a bulbous expansion of the aortic lumen.
- true aneurysm full-thickness expansion of the vessel wall
- pseudoaneurysm pseudoaneurysm
- the main surgical methods are: 1. Aortic aneurysm resection and artificial vessel transplantation to reconstruct the aorta; 2. Aortic aneurysm encapsulation; 3. Aortic aneurysm wall tumor resection.
- the above three kinds of surgical treatments are not only traumatic, long operation time, many complications, high mortality, and can be carried out under the support of extracorporeal circulation support and deep hypothermic circulatory stop, so the requirements for patients' general condition and medical technology are high. Moreover, even if an experienced surgeon performs surgical treatment on a patient with a well-functioning elective surgery, the operative mortality rate is still 12-15%.
- Interventional therapy is a treatment for aortic diseases developed after the 1990s. It is continuously applied to various incurable diseases, including: 1. Percutaneous endometrial fenestration, which is designed to be at the distal end of the dissection.
- the purpose is to return the blood flow of the false lumen of the dissection aneurysm to the true cavity, to relieve the acute abdominal cavity and lower limb ischemia caused by the expansion of the false cavity and the pressure of the true cavity.
- palliative surgery in order to fundamentally eliminate the false cavity and endometrial rupture, only as an emergency treatment for further interventional treatment for surgery time, has been used less.
- the length of the neck is large.
- Stanford B type thoracic aortic dissection aneurysm it requires aortic rupture position 15 mm beyond the left subclavian artery opening.
- abdominal aortic aneurysm between the proximal and lower renal arteries is required. The distance is greater than 15mm.
- the membranous stent opens the window.
- the so-called fenestration is to open the hole in the position of the important visceral artery opening such as the renal artery, so that the stent can be anchored across the important artery and completely isolate the interlayer rupture. And prevention of endoleak, can also ensure the smooth flow of arterial blood perfusion of the above-mentioned important organs.
- brackets are expensive.
- each person's aorta and the location, size, and direction of the opening of each branch are quite different, making it difficult to achieve individualized treatment.
- current imaging technology it is difficult to obtain accurate positioning of the three-dimensional space in the vascular lumen in vitro.
- the methods required for such stent implantation include silver clip marking, left subclavian artery, renal artery marking, multi-angle fluoroscopy, etc., which is very difficult to operate.
- the object of the present invention is to overcome the technical problem of fenestration of a stent in a vascular lumen, and to provide a fenestration method for a vascular stent and a fenestration device for a vascular stent, which can accurately locate
- the important artery branch covered by the stent graft is opened and the window is opened, and the blocked artery is opened, thereby achieving the interventional treatment of the patient with complicated aneurysm.
- the method for window opening of the intravascular stent graft comprises the following steps:
- the distance between the laser emitting port and the wall of the stent graft in the step 4) is 5-10 mm.
- the power of the laser beam in the step 4) is 10-300 MW, the wavelength is 500-10000 nm, and the frequency is 3 ⁇ 846-7 ⁇ 895 ⁇ 10" ⁇ .
- the power of the laser beam is 50-100 MW
- the wavelength is 3000-7000 nm
- the frequency is 4 ⁇ 568-6 ⁇ 755 ⁇ 10" ⁇ .
- the vascular intraluminal stent graft fenestration device designed by the invention comprises a control system and an outer sleeve, and a telescopic sleeve, a moving conduit and a laser optical cable located in the outer sleeve;
- the laser cable is provided with an emission port
- One end of the telescopic sleeve and one end of the moving conduit are respectively provided with a plurality of elastic wires and an ultrasonic positioning probe;
- the plurality of elastic wires are uniformly arranged in a trumpet shape, and one of the elastic wires is connected to the emission port;
- the moving conduit is located in the telescopic sleeve and the other end is connected to the control system;
- the control system is also connected to the other ends of the laser cable, the outer sleeve and the telescopic sleeve, respectively.
- the elastic metal wires have a total of six, and one of the elastic metal wires is connected to the emission port.
- the ultrasonic positioning probe comprises an X-ray marker and an ultrasound element.
- the elastic metal wire is a stainless steel wire or a titanium alloy wire.
- the invention has the beneficial effects: using the intravascular stent graft window opening method and the window opening device for in vivo stent graft fenestration will solve many vascular diseases that are currently clinically impossible to be implanted for stenting
- the surgical bottleneck problem of sick patients provides more survival opportunities for many patients; In-situ visibility operation is accurate, specific laser frequency window is safe, window opening with specific laser frequency, no damage to blood vessels, can be greatly Reduce the risk of surgery in patients.
- FIG. 1 is a schematic view showing the structure of a fenestration device for a stent in a vascular lumen according to the present invention.
- Fig. 2 is a schematic view showing the state of ultrasonic signal acquisition of the fenestration device of the intravascular stent graft in Fig. 1.
- Fig. 3 is a schematic view showing the laser windowing state of the fenestration device of the intravascular stent graft in Fig. 1.
- Fig. 4 is a schematic view showing the retracted state of the fenestration device of the intravascular stent graft in Fig. 1 after opening the window.
- 1-outer cannula 2-expansion cannula, 3-moving catheter, 4-ultrasonic positioning probe, 5-elastic wire, 6-laser cable (6.1 - launch port), 10-right renal artery, 11 - Abdominal aortic aneurysm, 12-stent graft.
- the intravascular stent graft fenestration device comprises a control system (not shown) and an outer cannula 1, and a telescopic sleeve 2, a mobile catheter 3 and a laser cable 6 located in the outer cannula 1;
- the laser cable 6 is provided with an emission port 6.1;
- One end of the telescopic sleeve 2 and one end of the moving duct 3 are respectively provided with six elastic wires 5 and an ultrasonic positioning probe 4;
- the six elastic wires 5 are evenly arranged in a trumpet shape, and one of the elastic wires 5 is connected to the emission port 6.1;
- the moving conduit 3 is located inside the telescopic sleeve 2 and is connected to the control system at the other end;
- the control system is also connected to the other ends of the laser cable 6, the outer casing 1 and the telescopic casing 2, respectively.
- the ultrasonic positioning probe 4 includes an X-ray marker (not shown) and an ultrasonic component (not shown).
- the elastic wire 5 is a stainless steel wire or a titanium alloy wire.
- control system generally includes an electronic control portion and a manual propulsion control portion.
- the electronic control part is connected with the ultrasonic positioning probe 4 and the laser optical cable 6, and its function is to acquire, analyze data, and control Laser emission.
- the manual propulsion control portion can be designed with a special mechanical structure respectively connected to the end of the outer sleeve 1, the rear end of the moving duct 3, and the other end of the telescopic sleeve 2 to assist the parts to accurately move back and forth, or to omit the manual propulsion control portion.
- the following is an example of venous fenestration repair of bilateral renal artery occlusion caused by endovascular grafting of complicated abdominal aortic aneurysm involving bilateral renal arteries, which illustrates the use of fenestration equipment in the vascular lumen.
- the procedure and the method of opening the window in the vascular lumen are illustrated.
- a method for opening a window in a vascular lumen comprising the following steps:
- the stent graft 12 is implanted into the intravascular (ie, intravascular lumen) of the abdominal aortic aneurysm 11 , and the left renal artery (not shown) and the right kidney are blocked outside the wall of the stent graft 12 .
- Intravascular stent graft fenestration device is guided by the guide wire, and one side of the femoral artery (such as the left femoral artery) enters the stent graft 12 of the abdominal aorta (ie, the X-ray marker is placed into the membrane)
- the ultrasonic positioning probe 4 is moved in the stent graft 12 at a controlled speed. Under the X-ray fluoroscopy condition, the X-ray marker in the ultrasonic positioning probe 4 can be used to substantially position the ultrasonic positioning probe 4 to be blocked.
- the position of the right renal artery 10 is open (ie, the position of the blocked right renal artery 10 vessel is initially positioned by X-ray), and the ultrasonic positioning probe 4 is contracted in the outer sleeve 1 and the telescopic sleeve 2;
- the ultrasonic positioning probe 4 from the outer cannula 1 and the telescopic cannula 2 (i.e., moving the ultrasonic component that has been placed in the stent graft 12 to the position of the 10th vascular orifice of the right renal artery that has been initially positioned)
- the image includes all measurement types of vascular local features such as plaques, vascular margins, etc., combined with preoperative imaging data and analysis.
- the data complete the three-dimensional reconstruction of the vascular lumen and the identification of the wall structure of the ultrasound, and accurately locate the three-dimensional spatial position of the 10 vascular orifice of the right renal artery;
- the telescopic sleeve 2 is extended from the outer sleeve 1 at this time, one end of the elastic wire 5 is opened and abuts against the inner wall of the stent graft 12, and then the telescopic sleeve 2 is rotated to connect the laser optical cable 6
- the elastic wire 5 is adjacent to the opening of the right renal artery 10, and the emission port 6.1 of the laser cable 6 is aligned with the opening of the right renal artery 10 (i.e., the laser emitting element that has been placed in the stent graft 12 is moved to
- the position of the right renal artery 10 vessel position has been accurately positioned, so that the laser emission port is as close as possible to the membranous branch
- the power of the laser beam is 70
- the instantaneous gasification blocks the film of the stent graft 12 at the opening of the right renal artery 10, and the stent graft 12 is opened.
- the window realizes the recanalization of the blood flow of the 10 vessels of the right renal artery.
- the ultrasonic positioning probe 4 and the telescopic sleeve 2 are retracted into the outer cannula 1, as shown in FIG. 4, the vascular opening device of the vascular stent is moved to the opening of the left renal artery, and the above step 2 is repeated. ) -4 ), to achieve blood flow recanalization of the left renal artery.
- the contrast agent is administered, and the left renal artery and the right renal artery 10 blocked by the stent graft 12 are reviewed. If the arterial perfusion is good, the vascular opening device of the vascular stent is slow overall. If the wall of the stent graft 12 at the left renal artery or the right renal artery 10 is small, the ultrasound can be used again, and then the laser is used to open the smaller opening in the stent graft 12. Enlargement, at the same time, a small stent can be inserted into the left or right renal artery 10 to completely block the blood flow leaking from the laser opening into the aneurysm or in the interlayer.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Prostheses (AREA)
Abstract
Description
脉管腔内覆膜支架开窗方法及脉管腔内覆膜支架开窗设备 技术领域 Vascular lumen stent graft window opening method and vascular lumen stent graft window opening device
本发明涉及脉管腔内覆膜支架技术领域, 具体地指一种脉管腔内覆膜支 架开窗方法及脉管腔内覆膜支架开窗设备。 背景技术 The invention relates to the technical field of intravascular stent grafts, in particular to a method for opening a window in a vascular lumen and a fenestration device for a stent in a vascular lumen. Background technique
主动脉瘤是最常见的动脉瘤, 是一种严重威胁人类生命的大血管疾病。 近年来随着高血压、 动脉硬化的发病率增加及人口老龄化, 主动脉瘤的发病 率也逐年增高, 成为中老年人猝死的常见原因之一。 其病因主要是主动脉中 层出现退行性病变, 进而导致主动脉壁变得薄弱、主动脉管腔的皮球样扩张。 按照病理解剖可分为: 真性动脉瘤 (血管壁的全层瘤样扩张)、 假性动脉瘤 Aortic aneurysm is the most common aneurysm and is a major vascular disease that seriously threatens human life. In recent years, with the increase in the incidence of hypertension and arteriosclerosis and the aging of the population, the incidence of aortic aneurysm has increased year by year, which has become one of the common causes of sudden death in middle-aged and elderly people. The cause is mainly degenerative lesions in the middle aorta, which in turn leads to a weakening of the aortic wall and a bulbous expansion of the aortic lumen. According to pathological anatomy, it can be divided into: true aneurysm (full-thickness expansion of the vessel wall), pseudoaneurysm
(多由与外伤血管破裂出血后被结缔组织包裹)、 夹层动脉瘤 (由于内膜局 部撕裂, 主动脉形成真假两腔后假腔的扩张)。 该疾病非常凶险, 致残致死 率高, 据相关报道主动脉瘤如不及时治疗, 五年生存率仅为 17%。 其中主动 脉夹层一旦发生, 如不采取积极治疗, 在发病的第一个 24 小时内死亡率可 达 21 %, 四天内达 49%, 一年内可达 93% ( Anagnostopoulos CE,Elefteriades JA,Doroghazi RM )。随着影像学技术的进步和对主动脉疾病的认识不短加深, 此类疾病的外科治疗手段也不断革新。 (Currently surrounded by connective tissue after rupture of traumatic blood vessels), dissecting aneurysm (due to the tearing of the endometrium, the aorta forms a true cavity and the expansion of the false lumen). The disease is very dangerous and has a high rate of disability and death. According to related reports, if the aortic aneurysm is not treated in time, the five-year survival rate is only 17%. In the case of aortic dissection, if no active treatment is taken, the mortality rate can reach 21% in the first 24 hours of the onset, 49% in four days, and 93% in one year ( Anagnostopoulos CE, Elefteriades JA, Doroghazi RM ). With advances in imaging technology and a deeper understanding of aortic diseases, surgical treatments for such diseases are constantly evolving.
90年代以前, 外科手术为主动脉疾病的主要治疗手段。 主要的手术方式 有: 1 .主动脉瘤切除人工血管移植重建主动脉; 2.主动脉瘤包裹术; 3.主动脉 瘤侧壁瘤体切除术。 上述三种手术治疗不仅创伤大, 手术时间长、 并发症多、 死亡率高, 需体外循环支持及深低体温循环停止的措施支持下才能开展, 故 对患者全身状况和医疗技术的要求高, 而且, 即使是在有经验的外科医生对 心功能良好的择期手术的病人进行外科治疗, 其手术死亡率仍在 12- 15%, Before the 1990s, surgery was the main treatment for aortic diseases. The main surgical methods are: 1. Aortic aneurysm resection and artificial vessel transplantation to reconstruct the aorta; 2. Aortic aneurysm encapsulation; 3. Aortic aneurysm wall tumor resection. The above three kinds of surgical treatments are not only traumatic, long operation time, many complications, high mortality, and can be carried out under the support of extracorporeal circulation support and deep hypothermic circulatory stop, so the requirements for patients' general condition and medical technology are high. Moreover, even if an experienced surgeon performs surgical treatment on a patient with a well-functioning elective surgery, the operative mortality rate is still 12-15%.
( DeBakey ME,Moreno-Cabral CE )病人出现截瘫的发生率在 5- 12%。 尤其是 主动脉瘤多发于高龄患者, 常合并心、 肝、 肺、 肾等多脏器功能不全和急诊 手术的病人, 手术死亡率更是高达 50 %或更高 (Moreno-Cabral CE )。 介入治疗是上世纪 90 年代后发展起来的主动脉疾病的治疗手段, 不断 被应用到各种疑难杂症中, 主要有: 1.经皮内膜开窗术, 其设计思路是在夹 层远端开窗, 使真假腔之间有平行血流, 目的是使夹层动脉瘤假腔的血流返 回真腔, 对于缓解假腔扩大、 真腔受压引起的急性腹腔脏器和下肢缺血起到 一定的作用, 但是毕竟是一种姑息性手术, 为从根本上消灭假腔及内膜破裂 口, 仅作为紧急治疗为进一步介入治疗争取手术时间, 目前已经较少采用。(DeBakey ME, Moreno-Cabral CE) The incidence of paraplegia in patients was 5-12%. In particular, aortic aneurysms are often found in elderly patients, often with heart, liver, lung, kidney and other multiple organ dysfunction and emergency surgery, the operative mortality rate is as high as 50% or higher (Moreno-Cabral CE). Interventional therapy is a treatment for aortic diseases developed after the 1990s. It is continuously applied to various incurable diseases, including: 1. Percutaneous endometrial fenestration, which is designed to be at the distal end of the dissection. Open the window, so that there is parallel blood flow between the true and false cavities, the purpose is to return the blood flow of the false lumen of the dissection aneurysm to the true cavity, to relieve the acute abdominal cavity and lower limb ischemia caused by the expansion of the false cavity and the pressure of the true cavity. To a certain role, but after all, is a kind of palliative surgery, in order to fundamentally eliminate the false cavity and endometrial rupture, only as an emergency treatment for further interventional treatment for surgery time, has been used less.
2.覆膜支架腔内隔绝术。 这一技术较常规的开放式外科手术具有创伤小、 术 后恢复快、 并发症少、 明显縮短住院时间等优势, 尤其是给了合并慢性疾病 不能耐受传统手术的高位高龄患者提供了治疗机会。 自 1991年 Parodi医生、 1994年 Dake医生和 1999年 Nienaber医生分别应用与腹主动脉瘤、 胸降主 动脉瘤及主动脉夹层的治疗并获得成功后, 现在主动脉腔内覆膜支架隔绝术 已经成为治疗动脉瘤的最佳选择, 开创了主动脉扩张性疾病治疗的里程碑。 现今, 已经在部分主动脉夹层、 主动脉真性动脉瘤、 主动脉假性动脉瘤等疾 病的治疗上取代了传统手术。 2. Endovascular grafting of the stent graft. This technique has the advantages of less trauma, faster postoperative recovery, less complications, and significantly shorter hospital stay than conventional open surgery, especially for high-aged patients with chronic diseases who cannot tolerate traditional surgery. . Since Dr. Parodi, Dr. Dake in 1994 and Dr. Nienaber in 1999 have been successfully treated with abdominal aortic aneurysm, thoracic descending aortic aneurysm and aortic dissection, now the aortic endoluminal stent graft has been It has become the best choice for the treatment of aneurysms, creating a milestone in the treatment of aortic dilatation diseases. Today, traditional surgery has been replaced in the treatment of some aortic dissections, aortic true aneurysms, and aortic pseudoaneurysms.
但是, 腔内覆膜支架植入术目前尚存在很多技术瓶颈, 主要体现在如下 三种情况: 1.近端瘤颈的曲度、 口径过大; 2.瘤颈处存在附壁血栓或斑块; However, there are still many technical bottlenecks in endoluminal stent graft implantation, which are mainly reflected in the following three situations: 1. The curvature and diameter of the proximal neck are too large; 2. There is a wall thrombus or plaque at the neck of the tumor. Piece;
3.瘤颈的长度较大。 对于 Stanford B型胸主动脉夹层动脉瘤腔内隔绝术, 其 要求主动脉裂口位置超出左锁骨下动脉开口 15mm, 对于腹主动脉瘤, 要求 瘤体近端与较低一支肾动脉之间的距离大于 15mm。 对于不能满足上述瘤颈 要求的病人如按常规治疗, 可供覆膜支架锚定的区域越短, 则术中、 术后极 容易出现覆膜支架的移位或者近端 I型内漏。 但是, 为了获得足够的锚定区 域, 往往需将左锁骨下动脉或肾动脉、 肠系膜上动脉、 腹腔干动脉一并封闭, 进一步导致相关重要脏器缺血等致命并发症。 因此, 约有 25-40%的患者不能 使用常规覆膜支架植入方法治疗, 弓降部主动脉瘤、 近肾主动脉瘤以及胸腹 主动脉瘤成为目前覆膜支架腔内隔绝术的难题。 3. The length of the neck is large. For Stanford B type thoracic aortic dissection aneurysm, it requires aortic rupture position 15 mm beyond the left subclavian artery opening. For abdominal aortic aneurysm, between the proximal and lower renal arteries is required. The distance is greater than 15mm. For patients who cannot meet the above-mentioned neck and neck requirements, the shorter the area that can be anchored by the stent graft, the more likely the stent graft is displaced or the proximal type I endoleak during and after surgery. However, in order to obtain a sufficient anchoring area, it is often necessary to close the left subclavian artery or the renal artery, the superior mesenteric artery, and the celiac trunk artery, further leading to fatal complications such as related organ ischemia. Therefore, about 25-40% of patients can not be treated with conventional stent-graft implantation. Bow-drop aortic aneurysm, proximal renal aortic aneurysm, and thoracic and abdominal aortic aneurysm become the current problem of endovascular graft exclusion. .
目前解决这一问题的方法有: 1.覆膜支架植入 +外科手术重建被封闭动 脉, 该方法不仅术前、 术后要反复造影评估涉及动脉血供, 而且, 要开放手 术重建腋动脉、 锁骨下动脉、 颈内动脉、 肾动脉、 腹腔干动脉、 肠系膜上动 脉。 仅仅适用于部分病情平稳、 一般情况尚可的择期手术病人, 对于急诊重 症病人目前尚未见有关机构手术成功报道, 手术难度、 手术风险、 手术时间 及创伤可见一斑, 很难在中层医疗机构推广开展, 且患者中长期预后尚不肯 定。 2.覆膜支架开窗, 所谓开窗就是就是在覆膜支架正对肾动脉等重要内脏 动脉开口的位置上开洞, 这样既能使覆膜支架跨越重要动脉进行锚定, 完全 隔绝夹层裂口及预防内漏, 又可以保证上述重要器官动脉血流灌注的通畅。 但是, 开窗支架制作技术难点在体外预先对覆膜支架开窗, 很难准确定位于 上述重要分支的开口处, 需结合 CTA成像 (层厚 1mm) 精确测量的基础上 定制。 从患者就诊到支架制作成功时间漫长, 很多病人在等待中病情加重甚 至猝死, 大大增加了此类病人的手术死亡率。 况且此类支架价格不菲。 不仅 如此, 由于个体差异, 每个人的主动脉以及各个分支的开口的部位、 大小、 方向差异较大, 很难实现个体化治疗。 就目前影像技术而言, 体外很难获得 脉管腔内三维空间的准确定位。 不仅如此, 此类支架植入需用的方法有银夹 标记、 左锁骨下动脉、 肾动脉标记、 多角度透视等方法, 操作难度非常大。 因此, 如何实现弓降部主动脉瘤、 近肾主动脉瘤以及胸腹主动脉瘤等复杂动 脉瘤患者覆膜支架的开窗, 成为介入治疗的国际难题。 发明内容 At present, the methods to solve this problem are as follows: 1. Covered stent implantation + surgical reconstruction of the closed artery. This method requires repeated angiographic evaluation of arterial blood supply before and after surgery, and open surgery to reconstruct the radial artery. Subclavian artery, internal carotid artery, renal artery, celiac trunk artery, mesenteric movement Pulse. It is only suitable for some patients with elective surgery with stable condition and general condition. For the emergency department, the successful operation of the relevant institutions has not been reported. The difficulty of surgery, the risk of surgery, the operation time and trauma are obvious. It is difficult to promote in middle-level medical institutions. , and the long-term prognosis of patients is not yet certain. 2. The membranous stent opens the window. The so-called fenestration is to open the hole in the position of the important visceral artery opening such as the renal artery, so that the stent can be anchored across the important artery and completely isolate the interlayer rupture. And prevention of endoleak, can also ensure the smooth flow of arterial blood perfusion of the above-mentioned important organs. However, it is difficult to open the window bracket in advance to open the window. It is difficult to accurately locate the opening of the important branch. It needs to be customized based on the accurate measurement of CTA imaging (layer thickness 1mm). From the patient visit to the stent production success time is long, many patients are aggravated or even drowned while waiting, greatly increasing the operative mortality rate of such patients. Moreover, such brackets are expensive. Not only that, because of individual differences, each person's aorta and the location, size, and direction of the opening of each branch are quite different, making it difficult to achieve individualized treatment. As far as current imaging technology is concerned, it is difficult to obtain accurate positioning of the three-dimensional space in the vascular lumen in vitro. Not only that, the methods required for such stent implantation include silver clip marking, left subclavian artery, renal artery marking, multi-angle fluoroscopy, etc., which is very difficult to operate. Therefore, how to achieve the fenestration of the stent graft in patients with complex aneurysms such as aortic aneurysm, proximal renal aortic aneurysm and thoracic and abdominal aortic aneurysm has become an international problem in interventional therapy. Summary of the invention
本发明的目的在于克服现有脉管腔内覆膜支架开窗的技术难题, 提供一 种脉管腔内覆膜支架开窗方法及脉管腔内覆膜支架开窗设备, 可以精确定位 被覆膜支架覆盖的重要动脉分支开口处并进行开窗, 开通被阻断动脉, 从而 实现了复杂动脉瘤患者的介入治疗。 The object of the present invention is to overcome the technical problem of fenestration of a stent in a vascular lumen, and to provide a fenestration method for a vascular stent and a fenestration device for a vascular stent, which can accurately locate The important artery branch covered by the stent graft is opened and the window is opened, and the blocked artery is opened, thereby achieving the interventional treatment of the patient with complicated aneurysm.
为实现上述目的, 本发明所设计的脉管腔内覆膜支架开窗方法, 包括如 下步骤: In order to achieve the above object, the method for window opening of the intravascular stent graft according to the present invention comprises the following steps:
1 ) 将覆膜支架植入脉管腔内, 使覆膜支架的管壁外侧至少阻断一个脉 管口; 1) implanting the stent graft into the vascular lumen such that at least one vessel mouth is blocked outside the tube wall of the stent graft;
2 ) 将 X射线标识置入覆膜支架内, 通过 X射线对被阻断的脉管口的位 置进行初步定位; 3 ) 将超声部件置入覆膜支架内并移动至已被初步定位的脉管口位置, 进行超声以采集局部脉管腔参数、 图像, 并传输、 存储, 分析所采集的数据, 完成超声处脉管腔的三维重建及管壁结构的识别, 对被阻断脉管口的三维空 间位置进行准确定位; 2) placing the X-ray marker into the stent graft, and initially positioning the blocked vessel mouth by X-ray; 3) Place the ultrasonic component into the stent graft and move to the position of the vessel position that has been initially positioned, perform ultrasound to collect local vascular lumen parameters and images, and transmit, store, analyze the collected data, and complete the ultrasound. Three-dimensional reconstruction of the vascular lumen and identification of the wall structure, accurate positioning of the three-dimensional spatial position of the blocked vessel orifice;
4 ) 将激光发射元件置入覆膜支架内并移动至已被准确定位的脉管口位 置, 使激光发射口靠近覆膜支架的管壁后触发激光束, 对覆膜支架进行开窗, 实现被阻断脉管口的血流再通。 4) Inserting the laser emitting element into the stent graft and moving to the position of the vessel port that has been accurately positioned, so that the laser emitting port is close to the wall of the stent graft, triggering the laser beam, and opening the window to realize the coating stent. The blood flow blocked by the vascular orifice is recanalized.
优选地, 所述步骤 4 ) 中激光发射口靠近覆膜支架的管壁的距离为 5- 10mm。 Preferably, the distance between the laser emitting port and the wall of the stent graft in the step 4) is 5-10 mm.
优选地, 所述步骤 4 ) 中激光束的功率为 10-300MW、 波长为 500- 10000nm、 频率为 3· 846-7 ·895χ 10"Ηζ。 Preferably, the power of the laser beam in the step 4) is 10-300 MW, the wavelength is 500-10000 nm, and the frequency is 3·846-7 · 895 χ 10" Ηζ.
更优选地, 所述激光束的功率为 50- 100MW、 波长为 3000-7000nm、 频 率为 4·568-6·755χ 10"Ηζ。 More preferably, the power of the laser beam is 50-100 MW, the wavelength is 3000-7000 nm, and the frequency is 4·568-6·755 χ 10" Ηζ.
本发明所设计的脉管腔内覆膜支架开窗设备, 包括控制系统和外套管, 以及位于外套管内的伸縮套管、 移动导管和激光光缆; The vascular intraluminal stent graft fenestration device designed by the invention comprises a control system and an outer sleeve, and a telescopic sleeve, a moving conduit and a laser optical cable located in the outer sleeve;
所述激光光缆设有发射口; The laser cable is provided with an emission port;
所述伸縮套管的一端和移动导管的一端分别设有多根弹性金属丝和超 声定位探头; One end of the telescopic sleeve and one end of the moving conduit are respectively provided with a plurality of elastic wires and an ultrasonic positioning probe;
所述多根弹性金属丝呈喇叭状均匀布置, 且其中一根弹性金属丝与发射 口相连; The plurality of elastic wires are uniformly arranged in a trumpet shape, and one of the elastic wires is connected to the emission port;
所述移动导管位于伸縮套管内且另一端与控制系统相连; The moving conduit is located in the telescopic sleeve and the other end is connected to the control system;
所述控制系统还分别与激光光缆、 外套管及伸縮套管的另一端相连。 优选地, 所述弹性金属丝共有六根, 且其中一根弹性金属丝与发射口相 连。 The control system is also connected to the other ends of the laser cable, the outer sleeve and the telescopic sleeve, respectively. Preferably, the elastic metal wires have a total of six, and one of the elastic metal wires is connected to the emission port.
优选地, 所述超声定位探头包括 X射线标识和超声元件。 Preferably, the ultrasonic positioning probe comprises an X-ray marker and an ultrasound element.
优选地, 所述弹性金属丝为不锈钢丝或钛合金丝。 Preferably, the elastic metal wire is a stainless steel wire or a titanium alloy wire.
本发明的有益效果: 利用脉管腔内覆膜支架开窗方法及开窗设备进行体 内覆膜支架开窗将解决许多现在临床上无法进行植入支架治疗相关血管疾 病的病患的手术瓶颈问题, 为众多患者提供更多生存的机会; 体外可视性操 作定位准确, 特定的激光频率开窗安全, 采用特定的激光频率开窗, 不会损 伤血管, 可以大大降低病人手术风险。 附图说明 The invention has the beneficial effects: using the intravascular stent graft window opening method and the window opening device for in vivo stent graft fenestration will solve many vascular diseases that are currently clinically impossible to be implanted for stenting The surgical bottleneck problem of sick patients provides more survival opportunities for many patients; In-situ visibility operation is accurate, specific laser frequency window is safe, window opening with specific laser frequency, no damage to blood vessels, can be greatly Reduce the risk of surgery in patients. DRAWINGS
图 1为本发明脉管腔内覆膜支架开窗设备的结构示意图。 1 is a schematic view showing the structure of a fenestration device for a stent in a vascular lumen according to the present invention.
图 2为图 1 中脉管腔内覆膜支架开窗设备的超声信号采集状态示意图。 图 3为图 1 中脉管腔内覆膜支架开窗设备的激光开窗状态示意图。 图 4为图 1 中脉管腔内覆膜支架开窗设备的开窗后回縮状态示意图。 图中: 1-外套管、 2-伸縮套管、 3-移动导管、 4-超声定位探头、 5-弹性金 属丝、 6-激光光缆 (6.1 -发射口)、 10-右肾动脉、 11 -腹主动脉瘤、 12-覆膜支 架。 具体实施方式 Fig. 2 is a schematic view showing the state of ultrasonic signal acquisition of the fenestration device of the intravascular stent graft in Fig. 1. Fig. 3 is a schematic view showing the laser windowing state of the fenestration device of the intravascular stent graft in Fig. 1. Fig. 4 is a schematic view showing the retracted state of the fenestration device of the intravascular stent graft in Fig. 1 after opening the window. In the figure: 1-outer cannula, 2-expansion cannula, 3-moving catheter, 4-ultrasonic positioning probe, 5-elastic wire, 6-laser cable (6.1 - launch port), 10-right renal artery, 11 - Abdominal aortic aneurysm, 12-stent graft. detailed description
以下结合具体实施例对本发明作进一步的详细描述。 The invention is further described in detail below with reference to specific embodiments.
如图 1所示, 脉管腔内覆膜支架开窗设备, 包括控制系统 (图未示) 和 外套管 1, 以及位于外套管 1 内的伸縮套管 2、 移动导管 3和激光光缆 6 ; 激光光缆 6设有发射口 6.1 ; As shown in Figure 1, the intravascular stent graft fenestration device comprises a control system (not shown) and an outer cannula 1, and a telescopic sleeve 2, a mobile catheter 3 and a laser cable 6 located in the outer cannula 1; The laser cable 6 is provided with an emission port 6.1;
伸縮套管 2的一端和移动导管 3的一端分别设有六根弹性金属丝 5和超 声定位探头 4 ; One end of the telescopic sleeve 2 and one end of the moving duct 3 are respectively provided with six elastic wires 5 and an ultrasonic positioning probe 4;
六根弹性金属丝 5呈喇叭状均匀布置, 且其中一根弹性金属丝 5与发射 口 6.1相连; The six elastic wires 5 are evenly arranged in a trumpet shape, and one of the elastic wires 5 is connected to the emission port 6.1;
移动导管 3位于伸縮套管 2内且另一端与控制系统相连; The moving conduit 3 is located inside the telescopic sleeve 2 and is connected to the control system at the other end;
控制系统还分别与激光光缆 6、 外套管 1及伸縮套管 2的另一端相连。 超声定位探头 4包括 X射线标识 (图未示) 和超声元件 (图未示)。 弹 性金属丝 5为不锈钢丝或钛合金丝。 The control system is also connected to the other ends of the laser cable 6, the outer casing 1 and the telescopic casing 2, respectively. The ultrasonic positioning probe 4 includes an X-ray marker (not shown) and an ultrasonic component (not shown). The elastic wire 5 is a stainless steel wire or a titanium alloy wire.
需要说明的是, 控制系统一般包括电控部分和手动推进控制部分。 电控 部分与超声定位探头 4、 激光光缆 6相连, 其功能为获取、 分析数据, 控制 激光发射。 手动推进控制部分可以设计专门的机械结构分别与外套管 1 的端 部、 移动导管 3的后端、 伸縮套管 2的另一端相连, 以协助各部分精确地前 后移动, 或者省略手动推进控制部分, 仅采用人手握住外套管 1 的端部、 移 动导管 3的后端, 伸縮套管 2的另一端进行推拉以控制各部分的前进后退。 It should be noted that the control system generally includes an electronic control portion and a manual propulsion control portion. The electronic control part is connected with the ultrasonic positioning probe 4 and the laser optical cable 6, and its function is to acquire, analyze data, and control Laser emission. The manual propulsion control portion can be designed with a special mechanical structure respectively connected to the end of the outer sleeve 1, the rear end of the moving duct 3, and the other end of the telescopic sleeve 2 to assist the parts to accurately move back and forth, or to omit the manual propulsion control portion. Only the end of the outer sleeve 1 is grasped by a human hand, the rear end of the moving duct 3 is moved, and the other end of the telescopic sleeve 2 is pushed and pulled to control the forward and backward of each part.
下面以累及双侧肾动脉的复杂腹主动脉瘤腔内隔绝术后, 造成的双侧肾 动脉阻塞的脉管腔内开窗修复为例, 说明脉管腔内覆膜支架开窗设备的使用 过程暨脉管腔内覆膜支架开窗方法。 The following is an example of venous fenestration repair of bilateral renal artery occlusion caused by endovascular grafting of complicated abdominal aortic aneurysm involving bilateral renal arteries, which illustrates the use of fenestration equipment in the vascular lumen. The procedure and the method of opening the window in the vascular lumen.
一种脉管腔内覆膜支架开窗方法, 包括如下步骤: A method for opening a window in a vascular lumen, comprising the following steps:
1 ) 将覆膜支架 12植入腹主动脉瘤 11处的血管内 (即脉管腔内), 覆膜 支架 12的管壁外侧有被阻断的左肾动脉 (图未示) 和右肾动脉 10脉管口; 1) The stent graft 12 is implanted into the intravascular (ie, intravascular lumen) of the abdominal aortic aneurysm 11 , and the left renal artery (not shown) and the right kidney are blocked outside the wall of the stent graft 12 . Arterial 10 vessel orifice;
2 ) 脉管腔内覆膜支架开窗设备在导丝的引导下, 由一侧股动脉 (如左 侧股动脉) 进入腹主动脉的覆膜支架 12 内 (即将 X射线标识置入覆膜支架 12内), 使超声定位探头 4在覆膜支架 12内按控制速度移动, 在 X射线透视 条件下, 利用超声定位探头 4内的 X射线标识, 可以实现大致定位超声定位 探头 4于被阻断的右肾动脉 10开口周围 (即通过 X射线对被阻断的右肾动 脉 10脉管口的位置进行初步定位), 此时超声定位探头 4縮在外套管 1和伸 縮套管 2内; 2) Intravascular stent graft fenestration device is guided by the guide wire, and one side of the femoral artery (such as the left femoral artery) enters the stent graft 12 of the abdominal aorta (ie, the X-ray marker is placed into the membrane) In the stent 12, the ultrasonic positioning probe 4 is moved in the stent graft 12 at a controlled speed. Under the X-ray fluoroscopy condition, the X-ray marker in the ultrasonic positioning probe 4 can be used to substantially position the ultrasonic positioning probe 4 to be blocked. The position of the right renal artery 10 is open (ie, the position of the blocked right renal artery 10 vessel is initially positioned by X-ray), and the ultrasonic positioning probe 4 is contracted in the outer sleeve 1 and the telescopic sleeve 2;
3 ) 使超声定位探头 4从外套管 1 和伸縮套管 2 内伸出 (即移动已置入 覆膜支架 12 内的超声部件至已被初步定位的右肾动脉 10 脉管口位置), 进 行超声以采集局部脉管腔参数、 图像, 并传输、 存储, 该图像包括了脉管腔 局部的特有属性的所有测量类型如斑块、 血管边缘等, 结合患者术前影像学 资料及分析所采集的数据, 完成超声处脉管腔的三维重建及管壁结构的识 别, 对右肾动脉 10脉管口的三维空间位置进行准确定位; 3) extending the ultrasonic positioning probe 4 from the outer cannula 1 and the telescopic cannula 2 (i.e., moving the ultrasonic component that has been placed in the stent graft 12 to the position of the 10th vascular orifice of the right renal artery that has been initially positioned) Ultrasound to acquire local venous parameters, images, and transmission and storage. The image includes all measurement types of vascular local features such as plaques, vascular margins, etc., combined with preoperative imaging data and analysis. The data, complete the three-dimensional reconstruction of the vascular lumen and the identification of the wall structure of the ultrasound, and accurately locate the three-dimensional spatial position of the 10 vascular orifice of the right renal artery;
4 ) 使伸縮套管 2从外套管 1 内伸出, 此时弹性金属丝 5 的一端张开并 抵接在覆膜支架 12的内壁上, 然后旋转伸縮套管 2, 使连接有激光光缆 6的 那一根弹性金属丝 5靠近右肾动脉 10的开口, 并使激光光缆 6的发射口 6.1 对准右肾动脉 10开口的方向 (即移动已置入覆膜支架 12内的激光发射元件 至已被准确定位的右肾动脉 10脉管口位置), 使激光发射口尽量靠近覆膜支 架 12的管壁, 但不要直接接触 (保持距离为 5- 10mm), 根据覆膜支架 12上 需要开口的大小, 准确确定所需激光的功率、 波长及频率后触发激光束 (本 实施例中, 所述激光束的功率为 70MW、 波长为 50000nm、 频率为 5.436x l 014Hz ) , 瞬间气化阻断右肾动脉 10开口处的覆膜支架 12的覆膜, 对 覆膜支架 12进行开窗, 实现右肾动脉 10脉管口的血流再通。 4) The telescopic sleeve 2 is extended from the outer sleeve 1 at this time, one end of the elastic wire 5 is opened and abuts against the inner wall of the stent graft 12, and then the telescopic sleeve 2 is rotated to connect the laser optical cable 6 The elastic wire 5 is adjacent to the opening of the right renal artery 10, and the emission port 6.1 of the laser cable 6 is aligned with the opening of the right renal artery 10 (i.e., the laser emitting element that has been placed in the stent graft 12 is moved to The position of the right renal artery 10 vessel position has been accurately positioned, so that the laser emission port is as close as possible to the membranous branch The wall of the frame 12, but not directly in contact (holding distance is 5-10 mm), according to the size of the opening required on the stent graft 12, accurately determine the power, wavelength and frequency of the laser required to trigger the laser beam (in this embodiment) The power of the laser beam is 70 MW, the wavelength is 50,000 nm, and the frequency is 5.436×10 14 Hz. The instantaneous gasification blocks the film of the stent graft 12 at the opening of the right renal artery 10, and the stent graft 12 is opened. The window realizes the recanalization of the blood flow of the 10 vessels of the right renal artery.
完成上述步骤后, 回縮超声定位探头 4和伸縮套管 2至外套管 1 中, 如 图 4所示, 移动脉管腔内覆膜支架开窗设备至左肾动脉开口处, 重复上述步 骤 2 ) -4 ), 实现左肾动脉的血流再通。 After the above steps are completed, the ultrasonic positioning probe 4 and the telescopic sleeve 2 are retracted into the outer cannula 1, as shown in FIG. 4, the vascular opening device of the vascular stent is moved to the opening of the left renal artery, and the above step 2 is repeated. ) -4 ), to achieve blood flow recanalization of the left renal artery.
最后, 在 X线透视下, 打造影剂, 复查原来被覆膜支架 12阻断的左肾 动脉和右肾动脉 10, 如果动脉灌注回复良好, 将脉管腔内覆膜支架开窗设备 整体缓慢拉出体外; 如果造影发现左肾动脉或右肾动脉 10处的覆膜支架 12 的管壁开口较小, 还可以再次利用超声定位后, 在覆膜支架 12 内再用激光 将较小的开口扩大, 同时, 还可在左肾动脉或右肾动脉 10 内置入带膜小支 架, 彻底封堵从激光开口处漏入到动脉瘤内或夹层内的血流。 Finally, under fluoroscopy, the contrast agent is administered, and the left renal artery and the right renal artery 10 blocked by the stent graft 12 are reviewed. If the arterial perfusion is good, the vascular opening device of the vascular stent is slow overall. If the wall of the stent graft 12 at the left renal artery or the right renal artery 10 is small, the ultrasound can be used again, and then the laser is used to open the smaller opening in the stent graft 12. Enlargement, at the same time, a small stent can be inserted into the left or right renal artery 10 to completely block the blood flow leaking from the laser opening into the aneurysm or in the interlayer.
Claims
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201320327091.0 | 2013-06-06 | ||
| CN201310225013.4A CN103349576B (en) | 2013-06-06 | 2013-06-06 | Windowing equipment for covered stent in vascular cavity |
| CN201320327091.0U CN203388961U (en) | 2013-06-06 | 2013-06-06 | Vascular endovascular stent graft windowing equipment |
| CN201310225013.4 | 2013-06-06 | ||
| CN 201310225012 CN103349575A (en) | 2013-06-06 | 2013-06-06 | Windowing method for covered stent in vascular cavity |
| CN201310225012.X | 2013-06-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2014194675A1 true WO2014194675A1 (en) | 2014-12-11 |
Family
ID=52007496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2014/070695 Ceased WO2014194675A1 (en) | 2013-06-06 | 2014-01-16 | Windowing method for covered stent in vascular cavity and windowing device for covered stent in vascular cavity |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2014194675A1 (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5617878A (en) * | 1996-05-31 | 1997-04-08 | Taheri; Syde A. | Stent and method for treatment of aortic occlusive disease |
| CN1391489A (en) * | 1999-09-23 | 2003-01-15 | 先进扩张技术公司 | Stent range transducers and methods of use |
| US6726677B1 (en) * | 1995-10-13 | 2004-04-27 | Transvascular, Inc. | Stabilized tissue penetrating catheters |
| WO2007082343A1 (en) * | 2006-01-17 | 2007-07-26 | Craig Steven Mclachlan | Method and device for graft fenestration |
| CN103040502A (en) * | 2012-12-04 | 2013-04-17 | 中国人民解放军第三军医大学第三附属医院 | Balloon needle for stent orthotopic fenestration |
| CN103349576A (en) * | 2013-06-06 | 2013-10-16 | 武汉杨森生物技术有限公司 | Windowing equipment for covered stent in vascular cavity |
| CN203388961U (en) * | 2013-06-06 | 2014-01-15 | 武汉杨森生物技术有限公司 | Vascular endovascular stent graft windowing equipment |
-
2014
- 2014-01-16 WO PCT/CN2014/070695 patent/WO2014194675A1/en not_active Ceased
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6726677B1 (en) * | 1995-10-13 | 2004-04-27 | Transvascular, Inc. | Stabilized tissue penetrating catheters |
| US5617878A (en) * | 1996-05-31 | 1997-04-08 | Taheri; Syde A. | Stent and method for treatment of aortic occlusive disease |
| CN1391489A (en) * | 1999-09-23 | 2003-01-15 | 先进扩张技术公司 | Stent range transducers and methods of use |
| WO2007082343A1 (en) * | 2006-01-17 | 2007-07-26 | Craig Steven Mclachlan | Method and device for graft fenestration |
| CN103040502A (en) * | 2012-12-04 | 2013-04-17 | 中国人民解放军第三军医大学第三附属医院 | Balloon needle for stent orthotopic fenestration |
| CN103349576A (en) * | 2013-06-06 | 2013-10-16 | 武汉杨森生物技术有限公司 | Windowing equipment for covered stent in vascular cavity |
| CN203388961U (en) * | 2013-06-06 | 2014-01-15 | 武汉杨森生物技术有限公司 | Vascular endovascular stent graft windowing equipment |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN201058061Y (en) | Branched vascular endografts in the aortic arch | |
| CN104905892B (en) | Integrated multiple branch intervenes arch of aorta overlay film frame | |
| EP3166524B1 (en) | Multi-pole synchronous pulmonary artery radiofrequency ablation catheter | |
| CN103349576B (en) | Windowing equipment for covered stent in vascular cavity | |
| CN106310495A (en) | Perfusion and dilation balloon system | |
| CN204971705U (en) | Integration multiple -limb type intervenes aortic arch tectorial membrane support | |
| CN107374779A (en) | A kind of local laser artery windowing facility and application thereof | |
| CN109172042A (en) | Ultrasound guidance laser in-situ window controlling system and its application method | |
| CN217723595U (en) | Aortic blood vessel blocking balloon catheter for controlling traumatic bleeding | |
| CN203388961U (en) | Vascular endovascular stent graft windowing equipment | |
| WO2014194675A1 (en) | Windowing method for covered stent in vascular cavity and windowing device for covered stent in vascular cavity | |
| CN118987454A (en) | Sheath tube assembly and interventional operation sheath tube assembly | |
| CN118766648A (en) | Thoracoabdominal aortic stent graft and endovascular treatment system | |
| CN113499088B (en) | An intraluminal closure system for visualization of lower extremity varicose veins | |
| CN114767327A (en) | Magnetic navigation catheter and navigation method for visceral artery reconstruction in artery stenting | |
| Itoh et al. | Vascular endoscopy for major vascular reconstruction: experimental and clinical studies | |
| CN111407463B (en) | Covered stent system | |
| Zhang et al. | The expression of MMP-7 in serum and aneurysm tissues of patients with abdominal aortic aneurysm associated with hypertension and the clinical efficacy of endovascular exclusion. | |
| CN103349575A (en) | Windowing method for covered stent in vascular cavity | |
| Pichlmaier et al. | The frozen elephant trunk technique | |
| CN222398556U (en) | Abdominal aorta-iliac artery integrated bracket | |
| CN209253228U (en) | Ultrasound-guided laser in-situ fenestration system | |
| Woelfle et al. | Intraoperative assessment of in situ saphenous vein bypass grafts by vascular endoscopy | |
| CN208659639U (en) | A kind of medical laser optical fiber | |
| CN222566031U (en) | Visceral artery in-situ windowing positioning mechanism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14806800 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 14806800 Country of ref document: EP Kind code of ref document: A1 |
|
| 32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 10.06.2016) |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 14806800 Country of ref document: EP Kind code of ref document: A1 |